Delcath (DCTH) 2026 Earnings Outlook: What Investors Need
Biotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
Compare tax exposure between dividend ETFs and taxable funds in 2024 to identify the lower-tax option for your goals.
28,172 articlesBiotech earnings season shines a spotlight on Delcath Systems. This guide breaks down the 2026 earnings outlook, key ...
As Nvidia signals AI momentum and Marvell rides the wave, investors scan AI bookings and data-center demand to gauge ...
A standout quarterly report helped Rhythm Pharmaceuticals stock surge on Tuesday as investors embraced better-than-ex...
The data center build-out accelerating wave is reshaping where investors place bets. Beyond chips, three infrastructu...
When a top Capricor executive liquidates stock, investors want to know what it means. This guide breaks down the trad...
Palantir sits at a crossroads of defense data and biotech action. This article explores why palantir's bold biosecuri...
Nvidia and Alphabet are leading a new era of high-growth tech. This deep dive breaks down why each company could reac...
Mastercard posts strong Q1 2026 results with rising services and margins, while PayPal signals a flat-to-down 2026. T...
As tensions flare, Qatar’s plan to buy $4 billion in Patriot missiles reshapes security and markets. This article bre...
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
A sudden regulatory shift around tokenized stocks has sparked a wave of excitement and confusion. This Morning Minute...
Taiwan Semiconductor's Q2 report is due July 16, shaping AI capex bets. Five stocks stand out as potential winners or...